Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;80(Suppl 1):S174-S179.
doi: 10.1016/j.mjafi.2023.03.004. Epub 2023 May 15.

Treating adult patients of severe psoriasis with methotrexate leads to reduction in biomarkers of atherosclerosis: A prospective study

Shekhar Neema  1 , Biju Vasudevan  2 , Pratibha Misra  3 , Roma Rai  4 , M K Sibin  5 , Senkadhir Vendhan  6 , Shantanu Banerjee  7 , Vinay Gera  8 , A K Yadav  9
Affiliations

Treating adult patients of severe psoriasis with methotrexate leads to reduction in biomarkers of atherosclerosis: A prospective study

Shekhar Neema et al. Med J Armed Forces India. 2024 Dec.

Abstract

Background: Psoriasis is a common skin disorder; affecting 0.4-2% of general population and is associated with increased risk of cardiovascular diseases. We conducted this prospective study to determine change in biomarkers of atherosclerosis in plaque psoriasis in patients treated with methotrexate.

Methods: The study was carried out at a tertiary care centre over a period of 1 year after institutional ethical clearance. The study included 50 patients. Adults with severe psoriasis not receiving any systemic treatment for last 3 months were included in the study. Clinical parameters including psoriasis area and severity index (PASI), dermatology quality of life index (DLQI) and estimation of IL-6, hsCRP, and HDL levels and LDL: HDL ratio were done at baseline and at 12 weeks.

Results: A total of 50 patients were included and 42 completed the study. The mean age and mean duration of disease was 44.4 (±13.2) years and 10.8 (±9.9) years, respectively. Pre- and post-treatment mean PASI was 16.3 (±8.3) and 7.43 (±4.9), respectively (p = 0.001). The level of VEGF, IL-6, and hsCRP was 127 (±158) pg/ml, 5.3 (±2.5) pg/ml, and 4.2 (±4.1) mg/L, respectively. The levels of VEGF, IL-6, and hsCRP after 12 weeks of treatment were found to be 59.3 (±61) pg/ml (p=0.006), 3.6 (±2.1) pg/ml (p < 0.001), and 2.6 (±3.1) mg/L (p = 0.012), respectively.

Conclusion: Methotrexate use in patients with chronic plaque psoriasis reduces the level of biomarkers of atherosclerosis at 12 weeks. Early treatment with methotrexate may help in reduction of cardiovascular risk in psoriasis patients.

Keywords: Cardiovascular risk; Comorbidities; Methotrexate; Psoriasis.

PubMed Disclaimer

Conflict of interest statement

The authors have none to declare.

Similar articles

See all similar articles

References

    1. Dogra S., Yadav S. Psoriasis in India: prevalence and pattern. Indian J Dermatol Venereol Leprol. 2010 Dec;76(6):595–601. - PubMed
    1. Rendon A., Schäkel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019 Mar 23;20(6):1475. - PMC - PubMed
    1. McDonald C.J., Calabresi P. Psoriasis and occlusive vascular disease. Br J Dermatol. 1978;99:469–475. - PubMed
    1. Ahlehoff O., Gislason G.H., Charlot M., et al. Psoriasis is associated with clinically significant cardiovascular risk: a Danish Nationwide cohort study: psoriasis and cardiovascular risk. J Intern Med. 2011;270:147–157. - PubMed
    1. Forkel S., Schön M., Hildmann A., et al. Inositoylated platelet-activating factor (Ino-C2-PAF) modulates dynamic lymphocyte-endothelial cell interactions and alleviates psoriasis-like skin inflammation in two complementary mouse models. J Invest Dermatol. 2014 Oct;134(10):2510–2520. - PubMed

LinkOut - more resources